Document is current
Any future updates will be listed below
-
Authors
Souto Filho, João Tadeu Damian https://orcid.org/0000-0003-2641-1425
Cantadori, Lucas Oliveira
Crusoe, Edvan de Queiroz https://orcid.org/0000-0002-8599-4731
Hungria, Vania https://orcid.org/0000-0002-4327-1957
Maiolino, Angelo https://orcid.org/0000-0003-0140-9548
- License Information
-
More Information
Article History
Received: 19 December 2024
Revised: 18 February 2025
Accepted: 7 March 2025
First Online: 13 March 2025
Competing interests
: JTDSF reported receiving honoraria from AbbVie, AstraZeneca, BeiGene, BMS, Johnson & Johnson, Novartis, and Sanofi. LOC reported receiving honoraria from Johnson & Johnson. EQC reported receiving research funding from Johnson & Johnson and honoraria from Amgen, BMS, Johnson & Johnson, Sanofi, GSK, and Takeda. VH reported receiving honoraria from BMS, GSK, Johnson & Johnson, Regeneron, Sanofi, Takeda, Amgen, and AbbVie. AM reported receiving honoraria from Johnson & Johnson, BMS, Sanofi, Takeda, Pfizer, and Amgen. No other disclosures were reported.
